Oncolytics Biotech Inc (NAS:ONCY)
$ 1.07 0 (0%) Market Cap: 82.02 Mil Enterprise Value: 64.91 Mil PE Ratio: 0 PB Ratio: 6.22 GF Score: 37/100

Q4 2021 Oncolytics Biotech Inc Earnings Call Transcript

Mar 03, 2022 / 10:00PM GMT
Release Date Price: $1.62 (-5.81%)
Operator

Good afternoon, and welcome to Oncolytics Biotech's Fourth Quarter 2021 Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

And I would like to turn the call over to Jon Patton, Director of Investor Relations and Communications. Please go ahead, sir.

Jon Patton
Oncolytics Biotech Inc. - Director of IR & Communication

Thank you, operator, and good afternoon, everyone. Earlier today, Oncolytics issued a press release providing recent operational highlights and financial results for the fourth quarter and full year 2021. A replay of today's call will be available on the Events and Presentations section of the Oncolytics website approximately 2 hours after its completion. After remarks from company management, we will open the call for Q&A.

As a reminder, various remarks made during this call contain certain forward-looking statements relating to our business prospects and the development and commercialization of pelareorep, including statements regarding our focus,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot